Logo image of REAL

REALREAL INC/THE (REAL) Stock Fundamental Analysis

NASDAQ:REAL - Nasdaq - US88339P1012 - Common Stock - Currency: USD

5.31  +0.07 (+1.34%)

After market: 5.2 -0.11 (-2.07%)

Fundamental Rating

2

REAL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 121 industry peers in the Specialty Retail industry. REAL may be in some trouble as it scores bad on both profitability and health. REAL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

REAL had negative earnings in the past year.
REAL had a positive operating cash flow in the past year.
In the past 5 years REAL always reported negative net income.
REAL had negative operating cash flow in 4 of the past 5 years.
REAL Yearly Net Income VS EBIT VS OCF VS FCFREAL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

The Return On Assets of REAL (-10.17%) is worse than 75.21% of its industry peers.
Industry RankSector Rank
ROA -10.17%
ROE N/A
ROIC N/A
ROA(3y)-33.77%
ROA(5y)-32.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
REAL Yearly ROA, ROE, ROICREAL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

REAL has a Gross Margin of 74.63%. This is amongst the best in the industry. REAL outperforms 96.69% of its industry peers.
In the last couple of years the Gross Margin of REAL has grown nicely.
REAL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.42%
GM growth 5Y3.19%
REAL Yearly Profit, Operating, Gross MarginsREAL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

0

2. Health

2.1 Basic Checks

REAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, REAL has more shares outstanding
REAL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, REAL has a worse debt to assets ratio.
REAL Yearly Shares OutstandingREAL Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
REAL Yearly Total Debt VS Total AssetsREAL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of -2.65, we must say that REAL is in the distress zone and has some risk of bankruptcy.
REAL has a Altman-Z score of -2.65. This is amonst the worse of the industry: REAL underperforms 88.43% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.65
ROIC/WACCN/A
WACC6.82%
REAL Yearly LT Debt VS Equity VS FCFREAL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

2.3 Liquidity

REAL has a Current Ratio of 0.87. This is a bad value and indicates that REAL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.87, REAL is doing worse than 80.99% of the companies in the same industry.
REAL has a Quick Ratio of 0.87. This is a bad value and indicates that REAL is not financially healthy enough and could expect problems in meeting its short term obligations.
REAL has a Quick ratio of 0.76. This is in the better half of the industry: REAL outperforms 66.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.76
REAL Yearly Current Assets VS Current LiabilitesREAL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.56% over the past year.
REAL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.87%.
REAL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.67% yearly.
EPS 1Y (TTM)51.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y8.69%
Revenue growth 5Y13.67%
Sales Q2Q%11.29%

3.2 Future

The Earnings Per Share is expected to grow by 32.02% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.89% on average over the next years. This is quite good.
EPS Next Y33.55%
EPS Next 2Y32.48%
EPS Next 3Y32.02%
EPS Next 5YN/A
Revenue Next Year9.53%
Revenue Next 2Y9.82%
Revenue Next 3Y9.49%
Revenue Next 5Y11.89%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
REAL Yearly Revenue VS EstimatesREAL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B
REAL Yearly EPS VS EstimatesREAL Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

1

4. Valuation

4.1 Price/Earnings Ratio

REAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year REAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
REAL Price Earnings VS Forward Price EarningsREAL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
REAL Per share dataREAL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

REAL's earnings are expected to grow with 32.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.48%
EPS Next 3Y32.02%

0

5. Dividend

5.1 Amount

No dividends for REAL!.
Industry RankSector Rank
Dividend Yield N/A

REALREAL INC/THE

NASDAQ:REAL (7/3/2025, 8:05:12 PM)

After market: 5.2 -0.11 (-2.07%)

5.31

+0.07 (+1.34%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners92.13%
Inst Owner Change15.86%
Ins Owners14.01%
Ins Owner Change-2.77%
Market Cap600.56M
Analysts78.33
Price Target10.2 (92.09%)
Short Float %22.03%
Short Ratio6.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.63%
Min EPS beat(2)7.73%
Max EPS beat(2)45.53%
EPS beat(4)3
Avg EPS beat(4)17.42%
Min EPS beat(4)-0.84%
Max EPS beat(4)45.53%
EPS beat(8)7
Avg EPS beat(8)24.55%
EPS beat(12)11
Avg EPS beat(12)21.54%
EPS beat(16)13
Avg EPS beat(16)16.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.81%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)-1.8%
Revenue beat(4)2
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)2%
Revenue beat(8)4
Avg Revenue beat(8)0.04%
Revenue beat(12)4
Avg Revenue beat(12)-0.87%
Revenue beat(16)7
Avg Revenue beat(16)-0.14%
PT rev (1m)1.01%
PT rev (3m)-7.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.18%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.01%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.97
P/FCF N/A
P/OCF 293.96
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.23
FCFYN/A
OCF(TTM)0.02
OCFY0.34%
SpS5.45
BVpS-2.97
TBVpS-2.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.63%
FCFM N/A
ROA(3y)-33.77%
ROA(5y)-32.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.42%
GM growth 5Y3.19%
F-Score6
Asset Turnover1.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 85.34%
Cap/Sales 4.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.87
Quick Ratio 0.76
Altman-Z -2.65
F-Score6
WACC6.82%
ROIC/WACCN/A
Cap/Depr(3y)115.01%
Cap/Depr(5y)137.9%
Cap/Sales(3y)6.04%
Cap/Sales(5y)7.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y33.55%
EPS Next 2Y32.48%
EPS Next 3Y32.02%
EPS Next 5YN/A
Revenue 1Y (TTM)11.87%
Revenue growth 3Y8.69%
Revenue growth 5Y13.67%
Sales Q2Q%11.29%
Revenue Next Year9.53%
Revenue Next 2Y9.82%
Revenue Next 3Y9.49%
Revenue Next 5Y11.89%
EBIT growth 1Y45.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year151.7%
EBIT Next 3Y48.44%
EBIT Next 5Y32.95%
FCF growth 1Y77.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.81%
OCF growth 3YN/A
OCF growth 5YN/A